Welcome!

News Feed Item

Big Pharma's Not the Only One Cashing in on the Human Growth Hormone "Anti-Aging" Craze

Critics Say SanMedica International's™ SeroVital™-hgh May Be Biggest Beneficiary of What Some Are Calling the hGH Revolution

NEW YORK, Jan. 4, 2013 /PRNewswire/ -- In September of 2012 at the prestigious Obesity Society's 30th Annual Scientific Meeting, a group of some of the most renowned research experts in the world revealed that a tiny little pill called SeroVital-hgh was actually capable of increasing mean serum (blood) growth hormone levels… by an astounding 682%. At that point, Big Pharma was no longer the only player in the growth hormone "Anti-Aging" craze.

Despite the fact that hGH is supposed to be a highly regulated substance prescribed to only a small group of patients with rare disorders, sales of the injections are surging. It seems the hormone's touted ability to rev up sex drive, decrease body fat, reduce wrinkles, increase lean muscle mass, boost energy has people desperate to get their hands on it. And many doctors are happy to hand out prescriptions, arguing that the anti-aging and health benefits many people claim to experience on the drug far outweigh any risks.

Rather than attempting to limit hGH sales to those with a legitimate medical need, prescription drug companies are cashing in on America's growing, billion-dollar obsession with hGH. And they're no longer the only ones. SeroVital-hgh has exploded onto the market and is quickly becoming the hottest hGH booster available. Why? Because while growth hormone injections introduce synthetic hGH — also called recombinant hGH, or rhGH — into the body, SeroVital raises growth hormone levels naturally. This, of course, has been headline news, because it means that after over 30 years of research, experts have finally developed an oral compound capable of increasing growth hormone levels naturally in the body… without expensive, synthetic injections.

The Pro Sports "Cheat" Pill?

And although SeroVital's specialized, amino-acid formula allows the product to steer clear of the controversy surrounding synthetic rhGH injections, it's still causing quite a stir in the sports industry. rhGH usage has been banned by virtually every sporting body in the world thanks to the unfair edge it gives users, but now it appears SeroVital may be giving competitive sports stars a "loophole" that will let them experience the benefits of increased growth hormone levels… without getting caught.

A recent Congressional hearing held December 12, 2012, revealed that the natural rise in hGH levels produced by SeroVital-hgh would not be picked up by anti-doping tests. Dr. Larry Bowers, Chief Science Officer for the United States Anti-Doping Agency who testified at the hearing, explained that while "The body produces many forms of growth hormone in the pituitary gland," synthetic rhGH injections involve only one form, called 22kD. hGH tests work by flagging people who have abnormally high ratios of 22kdD.

That's what makes SeroVital-hgh so different from synthetic rhGH injections. Rather than introducing a synthetic form of hGH into the body, SeroVital raises human growth hormone levels by encouraging pituitary health. This means there are no abnormally high levels of 22kD, because the increase in hGH comes from the body's natural source… the pituitary gland.

It seems SeroVital-hgh could be just what high-profile professional athletes are looking for to give them all the advantages of increased hGH levels… without the controversy surrounding synthetic rhGH injections, and without the fear of being sanctioned for illegal rhGH use. This could make SeroVital one of the most highly coveted supplements not only in the anti-aging industry, but also in the sports world… and it just might mean a privately owned company could finally give the Big Pharma boys a run for their money.

So What's the Catch?

Well, there are three. First, as with hGH injections, SeroVital-hgh is not a "magic bullet" but one part of a healthy lifestyle choice including a sensible diet and exercise regimen. And, just like hGH injections, you have to remember to renew your monthly supply.

Second, you have to take SeroVital-hgh on an empty stomach. That means you either have to take it first thing in the morning and then not eat anything for two hours, or take it at night, at least two hours after your last meal... before you go to bed.

And last but not least, while SeroVital is far less expensive than prescription hGH injections, it's still not cheap… SeroVital will cost you about $100 a month. But is it worth it? To most people, reducing wrinkles, decreasing body fat, increasing lean muscle mass, strengthening bones, boosting mood, while giving you plenty of energy and improving sex drive is a no brainer. However, make no mistake about it, the "established" medical community would say its benefits are largely anecdotal, with research that's preliminary. But there's no denying that something that has a chance of making you look and feel decades, not years, but DECADES younger, is... at the very least... irresistible.

SeroVital-hgh is currently being sold at Ulta stores throughout the U.S. and will soon be available at Sephora, as well. If it's sold out in stores, try buying it directly from SanMedica at www.SeroVital.com or 1-800-234-8207. It's not cheap, but if you use promo code SERO9 at checkout, you can get free shipping.Ɨ

†Free standard shipping in the continental U.S. only.
All trademarks are the property of their individual owners.

SOURCE SanMedica International

More Stories By PR Newswire

Copyright © 2007 PR Newswire. All rights reserved. Republication or redistribution of PRNewswire content is expressly prohibited without the prior written consent of PRNewswire. PRNewswire shall not be liable for any errors or delays in the content, or for any actions taken in reliance thereon.

Latest Stories
Machine learning provides predictive models which a business can apply in countless ways to better understand its customers and operations. Since machine learning was first developed with flat, tabular data in mind, it is still not widely understood: when does it make sense to use graph databases and machine learning in combination? This talk tackles the question from two ends: classifying predictive analytics methods and assessing graph database attributes. It also examines the ongoing lifecycl...
While some developers care passionately about how data centers and clouds are architected, for most, it is only the end result that matters. To the majority of companies, technology exists to solve a business problem, and only delivers value when it is solving that problem. 2017 brings the mainstream adoption of containers for production workloads. In his session at 21st Cloud Expo, Ben McCormack, VP of Operations at Evernote, discussed how data centers of the future will be managed, how the p...
Dion Hinchcliffe is an internationally recognized digital expert, bestselling book author, frequent keynote speaker, analyst, futurist, and transformation expert based in Washington, DC. He is currently Chief Strategy Officer at the industry-leading digital strategy and online community solutions firm, 7Summits.
Wooed by the promise of faster innovation, lower TCO, and greater agility, businesses of every shape and size have embraced the cloud at every layer of the IT stack – from apps to file sharing to infrastructure. The typical organization currently uses more than a dozen sanctioned cloud apps and will shift more than half of all workloads to the cloud by 2018. Such cloud investments have delivered measurable benefits. But they’ve also resulted in some unintended side-effects: complexity and risk. ...
With 10 simultaneous tracks, keynotes, general sessions and targeted breakout classes, @CloudEXPO and DXWorldEXPO are two of the most important technology events of the year. Since its launch over eight years ago, @CloudEXPO and DXWorldEXPO have presented a rock star faculty as well as showcased hundreds of sponsors and exhibitors! In this blog post, we provide 7 tips on how, as part of our world-class faculty, you can deliver one of the most popular sessions at our events. But before reading...
If a machine can invent, does this mean the end of the patent system as we know it? The patent system, both in the US and Europe, allows companies to protect their inventions and helps foster innovation. However, Artificial Intelligence (AI) could be set to disrupt the patent system as we know it. This talk will examine how AI may change the patent landscape in the years to come. Furthermore, ways in which companies can best protect their AI related inventions will be examined from both a US and...
In this presentation, you will learn first hand what works and what doesn't while architecting and deploying OpenStack. Some of the topics will include:- best practices for creating repeatable deployments of OpenStack- multi-site considerations- how to customize OpenStack to integrate with your existing systems and security best practices.
Charles Araujo is an industry analyst, internationally recognized authority on the Digital Enterprise and author of The Quantum Age of IT: Why Everything You Know About IT is About to Change. As Principal Analyst with Intellyx, he writes, speaks and advises organizations on how to navigate through this time of disruption. He is also the founder of The Institute for Digital Transformation and a sought after keynote speaker. He has been a regular contributor to both InformationWeek and CIO Insight...
Behera Rasananda is a technologist, a leader, a key note speaker has more than 20 years experience in across Government, Financial, Heath Care and Insurance Verticals. Mr. Behera has vast experience in Enterprise Cloud and Big Data solutions and Enterprise Architecture. Currently he works closely for Government Solutions on Enterprise Cloud for Federal Government Agency. Scientist Behera managed and partner with clients to make complete end to end solution and Migration to cloud both private sec...
Everyone wants the rainbow - reduced IT costs, scalability, continuity, flexibility, manageability, and innovation. But in order to get to that collaboration rainbow, you need the cloud! In this presentation, we'll cover three areas: First - the rainbow of benefits from cloud collaboration. There are many different reasons why more and more companies and institutions are moving to the cloud. Benefits include: cost savings (reducing on-prem infrastructure, reducing data center foot print, r...
They say multi-cloud is coming, but organizations are leveraging multiple clouds already. According to a study by 451 Research, only 21% of organizations were using a single cloud. If you've found yourself unprepared for the barrage of cloud services introduced in your organization, you will need to change your approach to engaging with the business and engaging with vendors. Look at technologies that are on the way and work with the internal players involved to have a plan in place when the ine...
Excitement and interest in APIs has skyrocketed in recent years. However, if you ask a room full of IT professionals "What is an API", you will get a wide array of answers. There exists a wide knowledge gap between API experts and those that have a general idea of what they are, but are unsure of what they have been for in the past, what they look like now, and how they can be used to expand your business in the future. In this session John will cover what the history of APIs, what an API looks ...
DXWorldEXPO LLC, the producer of the world's most influential technology conferences and trade shows has announced the 22nd International CloudEXPO | DXWorldEXPO "Early Bird Registration" is now open. Register for Full Conference "Gold Pass" ▸ Here (Expo Hall ▸ Here)
Bill Schmarzo, Tech Chair of "Big Data | Analytics" of upcoming CloudEXPO | DXWorldEXPO New York (November 12-13, 2018, New York City) today announced the outline and schedule of the track. "The track has been designed in experience/degree order," said Schmarzo. "So, that folks who attend the entire track can leave the conference with some of the skills necessary to get their work done when they get back to their offices. It actually ties back to some work that I'm doing at the University of ...
The now mainstream platform changes stemming from the first Internet boom brought many changes but didn’t really change the basic relationship between servers and the applications running on them. In fact, that was sort of the point. In his session at 18th Cloud Expo, Gordon Haff, senior cloud strategy marketing and evangelism manager at Red Hat, will discuss how today’s workloads require a new model and a new platform for development and execution. The platform must handle a wide range of rec...